ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Science Policy: Stem Cell Research Guidelines Formalize NIH Funding Polices

December 3, 1999

Clinical Oncology Programs Extended Two Years; No Decision Yet On Further Expansion

November 3, 1978

In Brief: NCI Study Finds No Relation Of Fluoridated Water To Cancer Incidence In U.S. Counties

December 5, 1975

Sexual Function Affected By Stem Cell Transplant

September 28, 2007

Varmus Projects FY2011 As “Particularly Tight”

November 12, 2010

Cancer Genetics Network approved By NCI Advisors, To Start With 8 Centers

November 29, 1996